Pharmacy Times May 13, 2022
Aklilu Tedla, vice president of strategy and business development at Cardinal Health, discusses the future of pharmacies as more cell and gene therapy products become available to patients.
Pharmacy Times interviewed Aklilu Tedla, vice president of strategy and business development at Cardinal Health, to discuss the future of pharmacies as more cell and gene therapy products become available to patients.
Question: What are some recent advancements in the cell and gene therapy space, and what has been the impact in the field?
Aklilu Tedla: Yeah, so today there are about 10 products in the marketplace, they span from medications that treat oncology, various neuromuscular types of issues to eye.
Just to give you a sense of the impact, for example,...
Today's Sponsors
Today's Sponsor